Seminar January 29, 2009

A Change is Gonna Come: How Will the New HHS and FDA Affect Pharmaceutical and Medical Device Companies?

Event Detail
Cathy L. Burgess
January 29, 2009

Cathy Burgess was a speaker during this audioconference sponsored by Thompson Interactive. The following topics were covered during the program.

  • Selection of Tom Daschle as HHS Secretary. What does this say about the Administration’s view of pharmaceutical and medical device companies?
  • Selection of CMS Administrator and FDA Commissioner. When will they be selected? What is the significance to industry?
  • Will President Obama’s Administration reverse preemption?
  • What other current FDA principles are likely to change?
  • What is the likelihood of the enactment of broad health care and/or Medicare reform in 2009?
  • How could President Obama’s expanded access plan impact

 

 

 

Meet The Speakers
Media Contacts
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement